Microneedle arrays integrated with living organisms for smart biomedical applications
Open Access
- 1 January 2021
- journal article
- review article
- Published by Ivyspring International Publisher in Theranostics
- Vol. 11 (20) , 10012-10029
Abstract
Various living organisms have proven to influence human health significantly, either in a commensal or pathogenic manner. Harnessing the creatures may remarkably improve human healthcare and cure the intractable illness that is challenged using traditional drugs or surgical approaches. However, issues including limited biocompatibility, poor biosafety, inconvenience for personal handling, and low patient compliance greatly hinder the biomedical and clinical applications of living organisms when adopting them for disease treatment. Microneedle arrays (MNAs), emerging as a promising candidate of biomedical devices with the functional diversity and minimal invasion, have exhibited great potential in the treatment of a broad spectrum of diseases, which is expected to improve organism-based therapies. In this review, we systemically summarize the technologies employed for the integration of MNAs with specific living organisms including diverse viruses, bacteria, mammal cells and so on. Moreover, their applications such as vaccination, anti-infection, tumor therapy and tissue repairing are well illustrated. Challenges faced by current strategies, and the perspectives of integrating more living organisms, adopting smarter materials, and developing more advanced technologies in MNAs for future personalized and point-of-care medicine, are also discussed. It is believed that the combination of living organisms with functional MNAs would hold great promise in the near future due to the advantages of both biological and artificial species.Keywords
This publication has 100 references indexed in Scilit:
- Dry-Coated Live Viral Vector Vaccines Delivered by Nanopatch Microprojections Retain Long-Term Thermostability and Induce Transgene-Specific T Cell Responses in MicePLOS ONE, 2013
- Vaccines against Tuberculosis: Where Are We and Where Do We Need to Go?PLOS Pathogens, 2012
- The human microbiome: at the interface of health and diseaseNature Reviews Genetics, 2012
- Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeysNature, 2012
- Profound early control of highly pathogenic SIV by an effector memory T-cell vaccineNature, 2011
- Risk factors in the development of stem cell therapyJournal of Translational Medicine, 2011
- Microneedle Arrays Allow Lower Microbial Penetration Than Hypodermic Needles In VitroPharmaceutical Research, 2009
- Safety and Immunogenicity of the Candidate Tuberculosis Vaccine MVA85A in West AfricaPLOS ONE, 2008
- Pathogen Recognition and Innate ImmunityCell, 2006
- Malariotherapy and cancerMedical Hypotheses, 1981